Stocks and Investing Stocks and Investing
Mon, September 25, 2023
[ 12:00 AM ] - WOPRAI
Ashish Sabadra Reiterated (ADT) at Hold and Held Target at $10 on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Brian Abrahams Reiterated (BCRX) at Buy and Held Target at $10 on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Brian Cheng Maintained (BCAB) at Buy with Decreased Target to $14 on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Paul Gait Downgraded (BHP) to Hold on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Boris Van Maintained (BIDU) at Buy with Increased Target to $168 on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Uy Ear Reiterated (ARQT) at Strong Buy and Held Target at $57 on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Ashish Sabadra Maintained (ARMK) at Hold with Decreased Target to $43 on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Brian Cheng Maintained (ALLO) at Buy with Decreased Target to $9 on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Lucas Pipes Maintained (AMRK) at Strong Buy with Decreased Target to $45 on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Yi Chen Initiated (ANGO) at Strong Buy and Held Target at $19 on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Reiterated (ANEB) at Strong Buy and Held Target at $6 on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Scott Devitt Reiterated (AMZN) at Buy and Held Target at $180 on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Joseph Feldman Reiterated (AMZN) at Buy and Held Target at $160 on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Deepak Mathivanan Initiated (CART) at Hold on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Robyn Karnauskas Reiterated (BMRN) at Strong Buy and Held Target at $140 on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Josh Siegler Reiterated (BITF) at Buy and Held Target at $3 on, Sep 25th, 2023
[ 12:00 AM ] - WOPRAI
Frederic Bastien Upgraded (BIP) to Strong Buy and Held Target at $45 on, Sep 25th, 2023
Fri, September 22, 2023
[ 12:00 AM ] - WOPRAI
Anthony Crowdell Maintained (BKH) at Sell with Decreased Target to $53 on, Sep 22nd, 2023
[ 12:00 AM ] - WOPRAI
Jonathan Reeder Maintained (BIP) at Buy with Decreased Target to $35 on, Sep 22nd, 2023
[ 12:00 AM ] - WOPRAI
Devin Dodge Maintained (BIP) at Buy with Decreased Target to $42 on, Sep 22nd, 2023
[ 12:00 AM ] - WOPRAI
Maurice Choy Reiterated (BIP) at Buy and Held Target at $45 on, Sep 22nd, 2023
[ 12:00 AM ] - WOPRAI
Jonathan Reeder Maintained (BIPC) at Buy with Decreased Target to $42 on, Sep 22nd, 2023
[ 12:00 AM ] - WOPRAI
Matt Miksic Maintained (BSX) at Buy with Increased Target to $60 on, Sep 22nd, 2023
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Reiterated (BWAY) at Strong Buy and Held Target at $12 on, Sep 22nd, 2023
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (CARR) at Hold with Increased Target to $59 on, Sep 22nd, 2023
[ 12:00 AM ] - WOPRAI
Jake Fuller Initiated (CART) at Hold on, Sep 22nd, 2023
[ 12:00 AM ] - WOPRAI
Michael Lavery Maintained (BYND) at Sell with Decreased Target to $3 on, Sep 22nd, 2023
[ 12:00 AM ] - WOPRAI
Joseph Feldman Reiterated (AMZN) at Buy and Held Target at $160 on, Sep 22nd, 2023
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Reiterated (AQST) at Strong Buy and Held Target at $5 on, Sep 22nd, 2023
[ 12:00 AM ] - WOPRAI
Andreas Argyrides Reiterated (AQST) at Buy and Held Target at $4 on, Sep 22nd, 2023

Andreas Argyrides Reiterated (AQST) at Buy and Held Target at $4 on, Sep 22nd, 2023


Published on 2024-10-28 06:33:01 - WOPRAI, Andreas Argyrides
  Print publication without navigation


Andreas Argyrides of Wedbush, Reiterated "Aquestive Therapeutics, Inc." (AQST) at Buy and Held Target at $4 on, Sep 22nd, 2023.

Andreas has made no other calls on AQST in the last 4 months.



There is 1 other peer that has a rating on AQST. Out of the 1 peers that are also analyzing AQST, 0 agree with Andreas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andreas

  • Jason Butler of "JMP Securities" Reiterated at Buy and Held Target at $8 on, Thursday, September 21st, 2023
Contributing Sources